MedPath

WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

Phase 2
Completed
Conditions
Adult Langerhans Cell Histiocytosis
Adult Acute Lymphoblastic Leukemia in Remission
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
Adult Grade III Lymphomatoid Granulomatosis
Angioimmunoblastic T-cell Lymphoma
Contiguous Stage II Adult Burkitt Lymphoma
Contiguous Stage II Adult Diffuse Large Cell Lymphoma
Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma
Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma
Interventions
Other: laboratory biomarker analysis
Other: enzyme-linked immunosorbent assay
First Posted Date
2011-01-10
Last Posted Date
2018-09-07
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
16
Registration Number
NCT01273766
Locations
🇺🇸

Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD)

Not Applicable
Completed
Conditions
Generalized Anxiety Disorder
Interventions
Behavioral: nondirective supportive therapy
Behavioral: cognitive behavioral therapy
First Posted Date
2010-12-14
Last Posted Date
2018-08-29
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
141
Registration Number
NCT01259596
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

Phase 2
Terminated
Conditions
Hypertension
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
First Posted Date
2010-11-04
Last Posted Date
2018-08-28
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
6
Registration Number
NCT01234922
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Yoga Therapy in Treating Patients With Malignant Brain Tumors

Not Applicable
Terminated
Conditions
Adult Ependymoma
Adult Gliosarcoma
Adult Grade II Meningioma
Adult Meningeal Hemangiopericytoma
Adult Anaplastic Oligodendroglioma
Adult Diffuse Astrocytoma
Adult Ependymoblastoma
Adult Giant Cell Glioblastoma
Adult Mixed Glioma
Adult Pineal Gland Astrocytoma
Interventions
Procedure: yoga therapy
Other: questionnaire administration
Procedure: quality-of-life assessment
First Posted Date
2010-11-04
Last Posted Date
2018-07-03
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
9
Registration Number
NCT01234805
Locations
🇺🇸

Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery

Phase 1
Terminated
Conditions
Mucinous Adenocarcinoma of the Rectum
Stage IIA Rectal Cancer
Stage IIB Rectal Cancer
Stage IIC Rectal Cancer
Stage IIIB Rectal Cancer
Stage IIIC Rectal Cancer
Interventions
Radiation: radiation therapy
Other: laboratory biomarker analysis
First Posted Date
2010-09-09
Last Posted Date
2018-07-02
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
2
Registration Number
NCT01197664
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

L-Carnitine Administration in Early Sepsis

Phase 1
Terminated
Conditions
Septic Shock
Interventions
Drug: Normal Saline
First Posted Date
2010-09-02
Last Posted Date
2022-04-22
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
31
Registration Number
NCT01193777
Locations
🇺🇸

University of Mississippi Medical Center, Jackson, Mississippi, United States

🇺🇸

Carolinas Medical Center, Charlotte, North Carolina, United States

Intravenous Interferon During Liver Transplant

Not Applicable
Completed
Conditions
Hepatitis C
Cirrhosis
Interventions
Drug: IV interferon
First Posted Date
2010-09-01
Last Posted Date
2022-04-21
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
15
Registration Number
NCT01192698

A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas

Phase 2
Completed
Conditions
Brain Tumors
Interventions
First Posted Date
2010-08-25
Last Posted Date
2023-06-12
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
23
Registration Number
NCT01188096
Locations
🇺🇸

RADY Children's Hospital, San Diego, California, United States

🇺🇸

Children's Healthcare of Atlanta, Atlanta, Georgia, United States

Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer

Not Applicable
Completed
Conditions
Liver Cancer
Adrenal Cancer
Non-Small-Cell Lung Carcinoma
Interventions
Radiation: stereotactic body radiation therapy
First Posted Date
2010-08-20
Last Posted Date
2019-11-29
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
29
Registration Number
NCT01185639
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

🇺🇸

Coastal Carolina Radiation Oncology, Wilmington, North Carolina, United States

Distal Locking Using an Electromagnetic Field Guided Computer Based Real Time System for Orthopaedic Trauma Patients

Not Applicable
Completed
Conditions
Tibial Fractures
Femoral Fractures
Interventions
Procedure: Wand technique
Procedure: free-hand
First Posted Date
2010-08-17
Last Posted Date
2023-05-16
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
55
Registration Number
NCT01183078
Locations
🇺🇸

Wake Forest University Health Sciences - CompRehab, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath